A Nomogram for Prediction of Overall Survival in Patients with Node-negative Gallbladder Cancer
- PMID: 31289596
- PMCID: PMC6603372
- DOI: 10.7150/jca.30046
A Nomogram for Prediction of Overall Survival in Patients with Node-negative Gallbladder Cancer
Abstract
Background & Aims: According to the stage of tumor, it's hard suitable to predict the prognosis for gallbladder cancer, especially for node-negative gallbladder cancer. Therefore, we aimed to create a nomogram based on demographic and clinicopathologic characteristics to estimate individualized potential impacts on postoperative overall survival. Methods: 789 patients with node-negative gallbladder cancer were selected from the Surveillance, Epidemiology, and End Results and randomly divided into training and internal validation group. Univariate and multivariate survival analysis were used to identify prognostic factors. The nomogram was constructed using Cox proportional hazards models. We evaluated the performance of the nomogram with Harrell's concordance index and calibration curve. The nomogram was externally validated in 115 patients with node-negative gallbladder cancer from the Sir Run Run Shaw hospital. Results: The nomogram for overall survival was built on the basis of five independent factors, such as age, sex, histology, T-stage, and number of examined lymph nodes. The C-index of nomogram for overall survival in the internal and external validation group was up to 0.724 and 0.716, respectively. Both of those calibration curves showed good agreement between predicted and observed outcomes in the 1-, 3-, 5-year overall survival. Compared to the 7th edition AJCC stage, the nomogram had a better difference in predicting overall survival, even could further classify patients into four risk subgroups in each stage. Conclusion: This nomogram can be used as a decision model to predict the outcomes of postoperative overall survival for node-negative gallbladder cancer, and may give useful guidance to clinicians for next treatment.
Keywords: gallbladder cancer; node-negative; nomogram; overall survival.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interest exists.
Figures




Similar articles
-
Prognostic Evaluation for Patients over 45 Years Old with Gallbladder Adenocarcinoma Resection: A SEER-Based Nomogram Analysis.Biomed Res Int. 2020 Jul 18;2020:6370946. doi: 10.1155/2020/6370946. eCollection 2020. Biomed Res Int. 2020. PMID: 32733948 Free PMC article.
-
A Novel Staging System to Forecast the Cancer-Specific Survival of Patients With Resected Gallbladder Cancer.Front Oncol. 2020 Jul 28;10:1281. doi: 10.3389/fonc.2020.01281. eCollection 2020. Front Oncol. 2020. PMID: 32850391 Free PMC article.
-
Development and validation of a nomogram to predict overall survival of T1 esophageal squamous cell carcinoma patients with lymph node metastasis.Transl Oncol. 2021 Aug;14(8):101127. doi: 10.1016/j.tranon.2021.101127. Epub 2021 May 18. Transl Oncol. 2021. PMID: 34020370 Free PMC article.
-
Development and external validation of a nomogram for predicting the effect of tumor size on cancer-specific survival of resected gallbladder cancer: a population-based study.Int J Clin Oncol. 2021 Jun;26(6):1120-1129. doi: 10.1007/s10147-021-01891-2. Epub 2021 Mar 5. Int J Clin Oncol. 2021. PMID: 33666788
-
CT-based nomogram for predicting survival after R0 resection in patients with gallbladder cancer: a retrospective multicenter analysis.Eur Radiol. 2021 May;31(5):3336-3346. doi: 10.1007/s00330-020-07402-7. Epub 2020 Nov 13. Eur Radiol. 2021. PMID: 33185751
Cited by
-
Prognostic Value of the Albumin-to-γ-glutamyltransferase Ratio for Gallbladder Cancer Patients and Establishing a Nomogram for Overall Survival.J Cancer. 2021 May 13;12(14):4172-4182. doi: 10.7150/jca.49242. eCollection 2021. J Cancer. 2021. PMID: 34093818 Free PMC article.
-
Development and validation of a prognostic nomogram for gallbladder cancer patients after surgery.BMC Gastroenterol. 2022 Apr 21;22(1):200. doi: 10.1186/s12876-022-02281-2. BMC Gastroenterol. 2022. PMID: 35448976 Free PMC article.
-
Strategies for the delay of surgery in the management of resectable hepatobiliary malignancies during the COVID-19 pandemic.Curr Oncol. 2020 Oct;27(5):e501-e511. doi: 10.3747/co.27.6785. Epub 2020 Oct 1. Curr Oncol. 2020. PMID: 33173390 Free PMC article. Review.
-
Development and Validation of a Nomogram for Predicting Survival in Gallbladder Cancer Patients With Recurrence After Surgery.Front Oncol. 2021 Jan 11;10:537789. doi: 10.3389/fonc.2020.537789. eCollection 2020. Front Oncol. 2021. PMID: 33505902 Free PMC article.
-
A Novel Prognostic Nomogram for Gallbladder Cancer after Surgical Resection: A Single-Center Experience.J Oncol. 2021 Feb 8;2021:6619149. doi: 10.1155/2021/6619149. eCollection 2021. J Oncol. 2021. PMID: 34447433 Free PMC article.
References
-
- Randi G, Malvezzi M, Levi F, Ferlay J, Negri E, Franceschi S. et al. Epidemiology of biliary tract cancers: an update. Ann Oncol. 2009;20:146–59. - PubMed
-
- Yee K, Sheppard BC, Domreis J, Blanke CD. Cancers of the gallbladder and biliary ducts. Oncology (Williston Park) 2002;16:939–46. 49; discussion 49-50, 52-3, 56-7. - PubMed
-
- Ferretti S, Gafa L. Upper gastrointestinal tract cancers: oesophagus, stomach, liver, gallbladder and biliary ducts, pancreas. Epidemiol Prev. 2004;28:34–42. - PubMed
-
- Tsukada K, Kurosaki I, Uchida K, Shirai Y, Oohashi Y, Yokoyama N. et al. Lymph node spread from carcinoma of the gallbladder. Cancer. 1997;80:661–7. - PubMed
LinkOut - more resources
Full Text Sources